Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Arterioscler Thromb Vasc Biol ; 32(3): 704-11, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22223730

RESUMO

OBJECTIVE: Tissue factor pathway inhibitor (TFPI) is the primary regulator of the tissue factor (TF) coagulation pathway. As such, TFPI may regulate the proangiogenic effects of TF. TFPI may also affect angiogenesis independently of TF, through sequences within its polybasic carboxyl terminus (TFPI C terminus [TFPIct]). We aimed to determine the effects of TFPI on angiogenesis and the role of TFPIct. METHODS AND RESULTS: Transgenic overexpression of TFPI attenuated angiogenesis in the murine hindlimb ischemia model and an aortic sprout assay. In vitro, TFPI inhibited endothelial cell migration. Peptides within the human TFPIct inhibited endothelial cell cord formation and migration in response to vascular endothelial growth factor (VEGF) 165 but not VEGF121. Furthermore, exposure to human TFPIct inhibited the phosphorylation of VEGF receptor 2 at residue Lys951, a residue known to be critical for endothelial cell migration. Finally, systemic delivery of a murine TFPIct peptide inhibited angiogenesis in the hindlimb model. CONCLUSION: These data demonstrate an inhibitory role for TFPI in angiogenesis that is, in part, mediated through peptides within its carboxyl terminus. In addition to its known role as a TF antagonist, TFPI, via its carboxyl terminus, may regulate angiogenesis by directly blocking VEGF receptor 2 activation and attenuating the migratory capacity of endothelial cells.


Assuntos
Inibidores da Angiogênese/metabolismo , Isquemia/metabolismo , Lipoproteínas/metabolismo , Músculo Esquelético/irrigação sanguínea , Neovascularização Fisiológica , Inibidores da Angiogênese/química , Inibidores da Angiogênese/deficiência , Inibidores da Angiogênese/genética , Inibidores da Angiogênese/farmacologia , Animais , Sítios de Ligação , Movimento Celular , Modelos Animais de Doenças , Heparina/metabolismo , Membro Posterior , Células Endoteliais da Veia Umbilical Humana/metabolismo , Humanos , Isquemia/genética , Isquemia/fisiopatologia , Lipoproteínas/química , Lipoproteínas/deficiência , Lipoproteínas/genética , Lipoproteínas/farmacologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Proteínas dos Microfilamentos/genética , Proteínas Musculares/genética , Neovascularização Fisiológica/efeitos dos fármacos , Peptídeos/farmacologia , Fosforilação , Regiões Promotoras Genéticas , Estrutura Terciária de Proteína , Fatores de Tempo , Receptor 2 de Fatores de Crescimento do Endotélio Vascular/metabolismo
2.
Curr Eye Res ; 33(11): 954-62, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19085378

RESUMO

PURPOSE: To determine the effect of keratocyte-derived MT1-MMP on calf pulmonary artery endothelial cell (CPAE) proliferation and migration. METHODS: Keratocyte lines were generated from MT1-MMP knockout (KO) and wild type (WT) mice. WT keratocytes were transfected with WT or mutant MT1-MMP DNAs (DeltaTC or E240A). The effect of keratocyte-conditioned media on CPAE proliferation and migration was assayed. RESULTS: KO keratocyte conditioned media resulted in the greatest increase of CPAE cell proliferation (190.5+/-6.0%; p<0.01). WT keratocyte conditioned media showed higher CPAE proliferation (155.4+/-3.6%) than WT/MT1-MMP-transfected keratocytes (119.7+/-2.2%; p<0.001). Migration assays confirmed these findings. CONCLUSIONS: Keratocyte-derived MT1-MMP has anti-angiogenic effects in CPAE cells.


Assuntos
Inibidores da Angiogênese/deficiência , Inibidores da Angiogênese/metabolismo , Córnea/enzimologia , Células Endoteliais/fisiologia , Metaloproteinase 14 da Matriz/deficiência , Metaloproteinase 14 da Matriz/metabolismo , Artéria Pulmonar/citologia , Inibidores da Angiogênese/genética , Inibidores da Angiogênese/farmacologia , Animais , Bovinos , Linhagem Celular Transformada , Movimento Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Córnea/citologia , Meios de Cultivo Condicionados/farmacologia , Células Endoteliais/citologia , Metaloproteinase 14 da Matriz/genética , Metaloproteinase 14 da Matriz/farmacologia , Camundongos , Camundongos Knockout , Mutação , Transfecção , Regulação para Cima
3.
Invest Ophthalmol Vis Sci ; 44(6): 2367-72, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12766032

RESUMO

PURPOSE: Collagen XVIII is expressed in ocular basement membranes (BMs) and inactivating mutations cause Knobloch syndrome, with several ocular abnormalities. In this study we investigated ocular structures in collagen XVIII/endostatin (Col18a1(-/-))-deficient mice to elucidate the role of this extracellular matrix component in the eye. METHODS: Eyes of Col18a1(-/-) and control mice were examined by light and transmission electron microscopy, laser scanning ophthalmoscopy, and fluorescence angiography. Immunohistochemical analysis of neuronal, epithelial, and immune cells in the eye was performed with antibodies against established cell markers. RESULTS: Col18a1(-/-) mice showed a disruption of the posterior iris pigment epithelial (IPE) cell layer with release of melanin granules. The BM of the posterior IPE was attached to the lens and the nonpigmented epithelium of the ciliary body, which was flattened in mutant mice. In aged mutant mice a severe thickening of the stromal iris BM zone was found, and pigmented cells migrated out of the iris and covered the retina along the inner limiting membrane (ILM), sometimes penetrating into the retina. These cells resembled iris clump cells, and immunohistochemistry demonstrated that they were macrophage-like cells. Furthermore, morphologically abnormal retinal vasculature was seen by fluorescence angiography. CONCLUSIONS: The abnormalities in the iris and ciliary body of Col18a1(-/-) mice demonstrate an important role of collagen XVIII for the function of ocular BMs. The absence of this collagen alters the properties of BMs and leads to severe defects in the iris, showing striking similarities to human pigment dispersion syndrome. In addition, loss of collagen XVIII creates changes that allow clump cells to migrate out of the iris. These cells have not been well characterized previously. In the current study we showed that they are macrophage-like cells and are able to penetrate the ILM in mutant mice. The disease mechanism of human pigment dispersion syndrome is not well understood, but Col18a1(-/-) mice may serve as a model and demonstrate the potential importance of alterations in extracellular matrix components in this disease.


Assuntos
Inibidores da Angiogênese/fisiologia , Colágeno/fisiologia , Síndrome de Exfoliação/etiologia , Anormalidades do Olho/etiologia , Doenças da Íris/etiologia , Iris/anormalidades , Fragmentos de Peptídeos/fisiologia , Envelhecimento , Inibidores da Angiogênese/deficiência , Animais , Membrana Basal/fisiologia , Membrana Basal/ultraestrutura , Corpo Ciliar/anormalidades , Corpo Ciliar/metabolismo , Corpo Ciliar/ultraestrutura , Colágeno/deficiência , Colágeno Tipo XVIII , Endostatinas , Síndrome de Exfoliação/metabolismo , Síndrome de Exfoliação/patologia , Matriz Extracelular/fisiologia , Matriz Extracelular/ultraestrutura , Anormalidades do Olho/metabolismo , Anormalidades do Olho/patologia , Feminino , Angiofluoresceinografia , Técnica Indireta de Fluorescência para Anticorpo , Iris/patologia , Doenças da Íris/metabolismo , Doenças da Íris/patologia , Masculino , Melaninas/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Microscopia Imunoeletrônica , Oftalmoscopia , Fragmentos de Peptídeos/deficiência , Epitélio Pigmentado Ocular/metabolismo , Epitélio Pigmentado Ocular/patologia , Epitélio Pigmentado Ocular/ultraestrutura , Doenças da Úvea/etiologia , Doenças da Úvea/metabolismo , Doenças da Úvea/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...